Immune checkpoint inhibitors and the pediatric rheumatologist: a pediatric needs assessment

Abstract Background The use of immune checkpoint inhibitor (ICI) therapy is increasing in pediatric oncology. ICIs can cause rheumatic-immune related adverse events (Rh-irAEs) such as inflammatory arthritis and myositis. Few case reports detail Rh-irAEs and their management in the pediatric populati...

Full description

Bibliographic Details
Published in:Pediatric Rheumatology Online Journal
Main Authors: John Storwick, Carrie Ye, Shahin Jamal, Nancy Maltez, Mercedes Chan
Format: Article
Language:English
Published: BMC 2025-07-01
Subjects:
Immune checkpoint inhibitors
IrAE
ICI
Needs assessment
Pediatrics
Rheumatic immune related adverse events
Online Access:https://doi.org/10.1186/s12969-025-01127-x

Internet

https://doi.org/10.1186/s12969-025-01127-x

Similar Items